Amandine L. Bourgeois

Nantes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Risk factors and Outcome of Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteraemia in High-Risk Neutropenic Patients in Haematology: A Multicentre Retrospective Study.

Risk factors and Outcome of Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteraemia in High-Risk Neutropenic Patients in Haematology: A Multicentre Retrospective Study.

Journal: International journal of antimicrobial agents
Published: February 16, 2026

Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients.

Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patients.

Journal: EJHaem
Published: June 08, 2023

Technique for treatment of recurrent perianal fistula in Crohn's disease using autologous fat.

Technique for treatment of recurrent perianal fistula in Crohn's disease using autologous fat.

Journal: Techniques in coloproctology
Published: March 21, 2023

Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplant.

Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplant.

Journal: Clinical and translational medicine
Published: January 03, 2023

Efficacy of anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation.

Efficacy of anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation.

Journal: EJHaem
Published: August 10, 2022

Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplant.

Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplant.

Journal: EJHaem
Published: January 31, 2022

Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.

Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.

Journal: Transplantation and cellular therapy
Published: April 20, 2021

Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome.

Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome.

Journal: Transplantation and cellular therapy
Published: February 02, 2021

Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.

Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: October 03, 2018
Showing 1-9 of 9

Last Updated: 09/26/2026